Cargando…
Why PB28 Could Be a Covid 2019 Game Changer?
[Image: see text] PB28, a cyclohexylpiperazine derivative, could be a potential strategy for Covid 19 because in a recent study it has been found more active than hydroxychloroquine without interaction with cardiac proteins. PB28 has been designed, developed, and biologically evaluated in the past d...
Autores principales: | Colabufo, Nicola Antonio, Leopoldo, Marcello, Ferorelli, Savina, Abate, Carmen, Contino, Marialessandra, Perrone, Maria Grazia, Niso, Mauro, Perrone, Roberto, Berardi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437449/ https://www.ncbi.nlm.nih.gov/pubmed/33052254 http://dx.doi.org/10.1021/acsmedchemlett.0c00271 |
Ejemplares similares
-
PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships
por: Abate, Carmen, et al.
Publicado: (2020) -
Receptor-Drug Interaction: Europium Employment for Studying the Biochemical Pathway of G-Protein-Coupled Receptor Activation
por: Antonio, Colabufo Nicola, et al.
Publicado: (2007) -
Multi-Target Directed Ligands (MTDLs) Binding the σ(1) Receptor as Promising Therapeutics: State of the Art and Perspectives
por: Abatematteo, Francesca Serena, et al.
Publicado: (2021) -
The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line
por: Pagliarulo, Vincenzo, et al.
Publicado: (2013) -
Small and Innovative Molecules as New Strategy to Revert MDR
por: Zinzi, Laura, et al.
Publicado: (2014)